Alkermes plc (ALKS) Tops Q2 EPS by 9c

Alkermes plc (NASDAQ: ALKS) reported Q2 EPS of ($0.01), $0.09 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $195.2 million versus the consensus estimate of $174.15 million.

GUIDANCE:

Alkermes plc sees FY2016 EPS of ($0.03)-($0.23). Alkermes plc sees FY2016 revenue of $710-760 million, versus the consensus of $738.03 million.

For earnings history and earnings-related data on Alkermes plc (ALKS) click here.

You May Also Be Interested In

• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• UBS Reiterates Buy Rating on Option Care Health (OPCH) Following Check-in Call Ahead of Quiet Period
• ’Not your father’s Sandisk’: Rosenblatt starts coverage at Buy